ExeVir Announces Close of US$50 million / EUR42 million Series A Financing

ExeVir Announces Close of US$50…

ExeVir Bio Announces New Publication from VIB Scientists Showing Potent and Broad Neutralizing Activity and Infection Protection Against SARS-COV, its Variants of Concern and Related Coronaviruses

ExeVir Bio Announces New Publication…

ExeVir Bio Appoints Michel Kazatchkine and Stef Heylen to the Board of Directors

ExeVir Bio Appoints Michel Kazatchkine…